January 16, 2018 5:22 AM ET

Pharmaceuticals

Company Overview of Beijing Tong Ren Tang Chinese Medicine Company Limited

Company Overview

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates in three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 67 retail outlets in 19 countries and regions. It markets its products under the Tong Ren Tang brand. The company was incorporated in 2004 and is based in Wanchai, Hong Kong. Beijing Tong Ren Tang Chinese Medicine Company Limited is a subsidiary of Tong Ren Tang Technologies Co., Ltd.

Office Tower

Room 1405-1409

Convention Plaza

1 Harbour Road

Wanchai,  

Hong Kong

Founded in 2004

705 Employees

Phone:

852 2881 7989

Fax:

852 2881 7606

Key Executives for Beijing Tong Ren Tang Chinese Medicine Company Limited

Vice Chairman, Chief Executive Officer, Compliance Officer and General Manager
Age: 54
Total Annual Compensation: $400.0K
Chief Financial Officer, Company Secretary and Executive Director
Age: 41
Total Annual Compensation: $1.7M
Deputy General Manager and Executive Director
Age: 57
Total Annual Compensation: $1.7M
Compensation as of Fiscal Year 2016.

Beijing Tong Ren Tang Chinese Medicine Company Limited Key Developments

Beijing Tong Ren Tang Chinese Medicine Company Limited, Special/Extraordinary Shareholders Meeting, Dec 01, 2017

Beijing Tong Ren Tang Chinese Medicine Company Limited, Special/Extraordinary Shareholders Meeting, Dec 01, 2017, at 14:00 China Standard Time. Location: Room 1405­1409, Office Tower Convention Plaza, 1 Harbour Road Wanchai Hong Kong Agenda: To approve, confirm and ratify the exclusive distributorship framework agreement entered into by the Company with Tong Ren Tang Technologies Co. Ltd. on 8 November 2017, and the new annual caps for the three years ending 31 December 2020 for the continuing connected transactions of the Company contemplated there under; and to approve, confirm and ratify the exclusive distributorship framework agreement entered into by the Company with Beijing Tong Ren Tang Company Limited on 8 November 2017, and the new annual caps for the three years ending 31 December 2020 for the continuing connected transactions of the Company contemplated thereunder.

Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Renewal of the Exclusive Distributorship Framework Agreements with Tong Ren Tang Technologies and Tong Ren Tang Ltd

Beijing Tong Ren Tang Chinese Medicine Company Limited announced New TRT Tech exclusive distributorship framework agreement with Tong Ren Tang Technologies. The New TRT Tech exclusive distributorship framework agreement shall be for a term of three years from 1 January 2018 to 31 December 2020 (both days inclusive) and shall be effective upon the approval of the Independent Shareholders at the EGM. The Tong Ren Tang Technologies Group appoints TRT International Natural-Pharm, a wholly-owned subsidiary of the company, as its sole overseas distributor for the distribution of the Relevant Products of the Tong Ren Tang Technologies Group in markets outside PRC. Within the term of the New TRT Tech Exclusive Distributorship Framework Agreement and for the purpose of the overseas distribution of the Relevant Products of the Tong Ren Tang Technologies Group, TRT International Natural-Pharm will procure from the Tong Ren Tang Technologies Group, and the Tong Ren Tang Technologies Group shall supply to TRT International Natural-Pharm, the Relevant Products as agreed by the parties. The Tong Ren Tang Technologies Group shall provide trainings on the Relevant Products of the Tong Ren Tang Technologies Group and the company is responsible for the registration and promotion of Relevant Products in markets outside PRC. Individual distribution agreement will be signed by members of the Tong Ren Tang Technologies Group and TRT International Natural-Pharm during the term of the New TRT Tech Exclusive Distributorship Framework Agreement to set out details of the quantity, price, specifications, standards, delivery time and settlement of the Relevant Products supplied, save as such individual distribution agreement shall be entered into on normal commercial terms as well as in accordance with the provisions of the New TRT Tech Exclusive Distributorship Framework Agreement. The company also announced new TRT Ltd. exclusive distributorship framework agreement with Tong Ren Tang Ltd. The New TRT Ltd. Exclusive Distributorship Framework Agreement shall be for a term of three years from 1 January 2018 to 31 December 2020 (both days inclusive) and shall be effective upon the approval of the Independent Shareholders at the EGM. The Tong Ren Tang Ltd. Group appoints TRT International Natural-Pharm, as its sole overseas distributor for the distribution of the Relevant Products of the Tong Ren Tang Ltd. Group in markets outside PRC. Within the term of the New TRT Ltd. Exclusive Distributorship Framework Agreement and for the purpose of the overseas distribution of the Relevant Products of the Tong Ren Tang Ltd. Group, TRT International Natural-Pharm will procure from the Tong Ren Tang Ltd. Group, and the Tong Ren Tang Ltd. Group shall supply to TRT International Natural-Pharm, the Relevant Products as agreed by the parties. The Tong Ren Tang Ltd. Group shall provide trainings on the Relevant Products of the Tong Ren Tang Ltd. Group and the Company is responsible for the registration and promotion of Relevant Products in markets outside PRC. Individual distribution agreement will be signed by members of the Tong Ren Tang Ltd. Group and TRT International Natural-Pharm during the term of the New TRT Ltd. Exclusive Distributorship Framework Agreement to set out details of the quantity, price, specifications, standards, delivery time and settlement of the Relevant Products supplied, save as such individual distribution agreement shall be entered into on normal commercial terms as well as in accordance with the provisions of the New TRT Ltd. Exclusive Distributorship Framework Agreement.

Beijing Tong Ren Tang Chinese Medicine Company Limited Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Ended September 30, 2017

Beijing Tong Ren Tang Chinese Medicine Company Limited announced unaudited consolidated earnings results for the third quarter and nine ended September 30, 2017. For the quarter, the company reported revenue of HKD 312,461,000 compared with HKD 266,292,000 for the same period a year ago. Operating profit was HKD 150,853,000 compared with HKD 132,371,000 for the same period a year ago. Profit before income tax was HKD 154,813,000 compared with HKD 133,626,000 for the same period a year ago. Profit attributable to owners of the company was HKD 124,758,000 compared with HKD 105,280,000 for the same period a year ago. Basic and diluted earnings per share was HKD 0.15 compared with HKD 0.13 for the same period a year ago. For the nine months, the company reported revenue of HKD 936,236,000 compared with HKD 808,242,000 for the same period a year ago. Operating profit was HKD 466,081,000 compared with HKD 418,526,000 for the same period a year ago. Profit before income tax was HKD 475,855,000 compared with HKD 422,322,000 for the same period a year ago. Profit attributable to owners of the company was HKD 382,107,000 compared with HKD 333,832,000 for the same period a year ago. Basic and diluted earnings per share was HKD 0.46 compared with HKD 0.40 for the same period a year ago.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Beijing Tong Ren Tang Chinese Medicine Company Limited, please visit www.tongrentangcm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.